Key result
Osteosarcopenia linked to greater cognitive impairment, frailty, and mortality than osteoporosis or sarcopenia alone.
Why the study?
Because osteosarcopenia is a newly defined syndrome, its interaction with physical dependence, frailty, and mortality in older adults remains unclear.
Does osteosarcopenia have a greater effect on daily living activities, frailty, mortality, and comorbidities than osteoporosis or sarcopenia alone in older people?
Cross-Sectional
Does osteosarcopenia have a greater effect on daily living activities, frailty, mortality, and comorbidities than osteoporosis or sarcopenia alone in older people?
Should not yet guide geriatric assessments; leaves open additive risks of osteosarcopenia for frailty and mortality.
Objective: Osteosarcopenia is a relatively new defined syndrome in older people, elucidated as the coexistence of osteoporosis and sarcopenia. As this syndrome is newly defined, the interaction between physical dependence, frailty and mortality in older adults is not clear. To determine whether osteosarcopenia (OSP) has a greater effect on daily living activities, frailty, mortality, comorbidities than osteoporosis (OP) and sarcopenia (SP) alone.
No takes yet. Share an insight, caveat, or question.
Öztorun et al. (2021) conducted a cross-sectional in Osteosarcopenia. Osteosarcopenia vs. Osteoporosis and sarcopenia alone was evaluated on Daily living activities, frailty, mortality, comorbidities. Osteosarcopenia may cause cognitive impairment, frailty, and mortality in older people compared to osteoporosis or sarcopenia alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: